Annual report
5201.TEDINET S100XSTU
Period2025-01-01 → 2025-12-31
Filed2026-03-24
StandardIFRS
ConsolidatedYes
Data checks19 of 19 passed
Key figures · 155
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.06T | 2025-01-01 → 2025-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥2.07T | 2024-01-01 → 2024-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥2.02T | 2023-01-01 → 2023-12-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥2.04T | 2022-01-01 → 2022-12-31v | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.70T | 2021-01-01 → 2021-12-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥127.5bn | 2025-01-01 → 2025-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥125.8bn | 2024-01-01 → 2024-12-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥124.8bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥50.0bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥122.8bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥58.5bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥210.0bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥69.2bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥94.0bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥65.8bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥3.2bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥123.8bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥79.5bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss IFRS |
| Net income | −¥77.9bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss IFRS |
| Total assets | ¥2.95T | at 2025-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.89T | at 2024-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.93T | at 2023-12-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.81T | at 2022-12-31v | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥2.67T | at 2021-12-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥1.22T | at 2025-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.22T | at 2024-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥1.73T | at 2025-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.67T | at 2024-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.65T | at 2023-12-31v | Cons. | Equity IFRS |
| Equity (owners) | ¥1.49T | at 2025-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.44T | at 2024-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.45T | at 2023-12-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.39T | at 2022-12-31v | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥1.31T | at 2021-12-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥94.7bn | at 2025-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥108.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥146.1bn | at 2023-12-31v | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥209.7bn | at 2022-12-31v | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥195.8bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥274.5bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥284.8bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥212.5bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥217.1bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥326.7bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | −¥178.4bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥195.6bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥179.8bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥145.3bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥123.8bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥114.1bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥131.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥108.0bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥78.2bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥252.3bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥326.2 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-443.71 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥304.73 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-14.22 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥559.11 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥325.67 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-443.71 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥304.01 | 2023-01-01 → 2023-12-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-14.22 | 2022-01-01 → 2022-12-31v | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥557.1 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥7,003.63 | at 2025-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥6,773.86 | at 2024-12-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥6,831.89 | at 2023-12-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥6,271.35 | at 2022-12-31v | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥5,930.27 | at 2021-12-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 50.3% | at 2025-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 49.7% | at 2024-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 49.3% | at 2023-12-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 49.4% | at 2022-12-31v | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 49.3% | at 2021-12-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 4.7% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -6.5% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 4.6% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -0.2% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 10.2% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 52,896 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 53,687 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 56,724 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 57,609 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 55,999 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥652.7bn | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥653.7bn | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥667.0bn | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥631.8bn | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥566.8bn | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥40.3bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | ¥29.1bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥120.9bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥94.3bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥115.1bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥103.8bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥124.0bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥135.9bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥14.6bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | ¥117.6bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | −¥20.8bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥112.9bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥46.7bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥117.2bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.41T | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥1.33T | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥1.39T | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.34T | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.36T | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥661.8bn | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥648.0bn | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥751.0bn | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥680.8bn | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥753.8bn | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥738.8bn | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥757.9bn | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥554m | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥607m | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥554.77 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-98.26 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥522.9 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥210.66 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥529.34 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥553.86 | 2025-01-01 → 2025-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥521.66 | 2023-01-01 → 2023-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥210.07 | 2022-01-01 → 2022-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥527.43 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥210 | 2025-01-01 → 2025-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥210 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥210 | 2023-01-01 → 2023-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥210 | 2022-01-01 → 2022-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥210 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥3,538.5 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,207.79 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,553.98 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,327.03 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,413.15 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 53.1% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.2% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.3% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.1% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.5% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.4% | 2025-01-01 → 2025-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 15.2% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2022-01-01 → 2022-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.3% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 217,434,000 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 217,434,000 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 217,434,000 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 227,441,000 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 227,441,000 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 8,122 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 8,014 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 7,753 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 7,412 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 7,223 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2025-01-01 → 2025-12-31 | −¥20m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-12-31 | ¥51m |
| Automotivereportable segment | capex | 2025-01-01 → 2025-12-31 | ¥43.1bn |
| Automotivereportable segment | employees | at 2025-12-31 | 15997 pure |
| Automotivereportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥29.3bn |
| Glassreportable segment | capex | 2025-01-01 → 2025-12-31 | ¥33.1bn |
| Glassreportable segment | employees | at 2025-12-31 | 12697 pure |
| Glassreportable segment | segment profit | 2025-01-01 → 2025-12-31 | ¥17.3bn |
| Lifesciencereportable segment | capex | 2025-01-01 → 2025-12-31 | ¥28.1bn |
| Lifesciencereportable segment | employees | at 2025-12-31 | 2967 pure |
| Lifesciencereportable segment | segment profit | 2025-01-01 → 2025-12-31 | −¥22.3bn |
| —segment total | employees | at 2025-12-31 | 49160 pure |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-01-01 → 2025-12-31 | ¥251.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-12-31 | ¥127.4bn |
| Reconciling Itemsreconciling | capex | 2024-01-01 → 2024-12-31 | −¥43m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-12-31 | ¥350m |
| Automotivereportable segment | capex | 2024-01-01 → 2024-12-31 | ¥35.5bn |
| Automotivereportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥13.9bn |
| Glassreportable segment | capex | 2024-01-01 → 2024-12-31 | ¥33.8bn |
| Glassreportable segment | segment profit | 2024-01-01 → 2024-12-31 | ¥16.4bn |
| Lifesciencereportable segment | capex | 2024-01-01 → 2024-12-31 | ¥35.8bn |
| Lifesciencereportable segment | segment profit | 2024-01-01 → 2024-12-31 | −¥21.2bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-01-01 → 2024-12-31 | ¥257.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-12-31 | ¥125.5bn |
| Automotivereportable segment | employees | at 2025-12-31 | 1885 pure |
| Glassreportable segment | employees | at 2025-12-31 | 479 pure |
| Lifesciencereportable segment | employees | at 2025-12-31 | 379 pure |
| —segment total | employees | at 2025-12-31 | 6013 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 2,232
| Item | Context | Value | Unit |
|---|---|---|---|
| Intersegment sales IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000LifescienceReportableSegmentMember | 3661000000 | JPY |
| Intersegment sales IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000CeramicsOthersMember | 22323000000 | JPY |
| Intersegment sales IFRS | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 35082000000 | JPY |
| Intersegment sales IFRS | CurrentYearDuration_ReconcilingItemsMember | -35082000000 | JPY |
| Intersegment sales IFRS | CurrentYearDuration | － | JPY |
| Net sales IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000GlassReportableSegmentMember | 441141000000 | JPY |
| Net sales IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000AutomotiveReportableSegmentMember | 520580000000 | JPY |
| Net sales IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000ElectronicsMember | 355054000000 | JPY |
| Net sales IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000ChemicalsMember | 584174000000 | JPY |
| Net sales IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000LifescienceReportableSegmentMember | 133081000000 | JPY |
| Net sales IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000CeramicsOthersMember | 59884000000 | JPY |
| Net sales IFRS | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 2093915000000 | JPY |
| Net sales IFRS | CurrentYearDuration_ReconcilingItemsMember | -35082000000 | JPY |
| Net sales IFRS | CurrentYearDuration | 2058832000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000GlassReportableSegmentMember | 17263000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000AutomotiveReportableSegmentMember | 29252000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000ElectronicsMember | 47536000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000ChemicalsMember | 53035000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000LifescienceReportableSegmentMember | -22261000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000CeramicsOthersMember | 2588000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 127414000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration_ReconcilingItemsMember | 51000000 | JPY |
| Operating profit loss IFRS | CurrentYearDuration | 127465000000 | JPY |
| Profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000GlassReportableSegmentMember | － | JPY |
| Profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000AutomotiveReportableSegmentMember | － | JPY |
| Profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000ElectronicsMember | － | JPY |
| Profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000ChemicalsMember | － | JPY |
| Profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000LifescienceReportableSegmentMember | － | JPY |
| Profit loss IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000CeramicsOthersMember | － | JPY |
| Profit loss IFRS | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Profit loss IFRS | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Profit loss IFRS | CurrentYearDuration | 79470000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000GlassReportableSegmentMember | 26194000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000AutomotiveReportableSegmentMember | 31839000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000ElectronicsMember | 49601000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000ChemicalsMember | 55355000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000LifescienceReportableSegmentMember | 15282000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000CeramicsOthersMember | 1671000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 179945000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration_ReconcilingItemsMember | -148000000 | JPY |
| Depreciation and amortization operating expenses IFRS | CurrentYearDuration | 179796000000 | JPY |
| Impairment losses total pl IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000GlassReportableSegmentMember | 179000000 | JPY |
| Impairment losses total pl IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000AutomotiveReportableSegmentMember | － | JPY |
| Impairment losses total pl IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000ElectronicsMember | 3141000000 | JPY |
| Impairment losses total pl IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000ChemicalsMember | 213000000 | JPY |
| Impairment losses total pl IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000LifescienceReportableSegmentMember | 7781000000 | JPY |
| Impairment losses total pl IFRS | CurrentYearDuration_jpcrp030000-asr_E01122-000CeramicsOthersMember | 1146000000 | JPY |
| Impairment losses total pl IFRS | CurrentYearDuration_TotalOfReportableSegmentsAndOthersMember | 12461000000 | JPY |
| Impairment losses total pl IFRS | CurrentYearDuration_ReconcilingItemsMember | － | JPY |
| Impairment losses total pl IFRS | CurrentYearDuration | 12461000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 19 of 19 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |